IP Library Granted Patent US 10,370,362
Granted Patent B2
US 10,370,362 · App. 14/962,242 · Granted Aug 6, 2019

Pyrazine derivatives with extended conjugation and methods of using the same in optical applications

Inventors: William L. Neumann (St. Louis, MO); Raghavan Rajagopalan (Solon, OH); Richard B. Dorshow (St. Louis, MO)
Assignee: MediBeacon Inc.
C07D405/04A61K49/0021C07D241/12C07D241/20C07D241/24C07D241/26C07D241/28C07D401/04C07D401/14C07D403/04C07D403/12C07D403/14C07D409/04C07D409/06C07D409/10C07D409/14C07D413/04C07D417/04C07D473/18C07D473/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,370,362
App. No.
14/962,242
Granted
Aug 6, 2019
Kind
B2
Abstract

The present invention relates to pyrazine derivatives capable of absorbing and emanating spectral energy in the visible and/or near infrared spectrum. Pyrazine derivatives of the invention may be administered to a patient in the form of a pharmaceutically acceptable composition and utilized in medical (e.g., diagnostic imaging) procedures.

Claims (61)

1. An optical diagnostic agent having Formula 1

or pharmaceutically acceptable salt thereof, wherein:

X is -Ar-Y, —C(R 4 )═C(R 5 )-Ar-Y, —C≡C-Ar-Y, —N═N-Ar-Y, —CO-Ar-Y, —N(R 6 )-Ar-Y, —O-Ar-Y, —S-Ar-Y, —SO-Ar-Y, —SO 2 -Ar-Y, —C(R 4 )═C(R 5 )—Y, or —C≡C—Y;

Ar is phenyl, naphthyl, biphenyl, pyridyl, pyridazyl, pyrimidinyl, pyrazinyl, pyrrolyl, furanyl, thiopheneyl, pyrazolyl, imidazolyl, oxazolyl, thiazolyl, triazinyl, triazolyl or thiadiazolyl; with the proviso that if Ar is phenyl, pyrrolyl, or thiopheneyl, then at least one of R 1 , R 2 , and R 3 is other than hydrogen;

each Y is independently hydrogen, C 1 -C 10 alkyl, halo, haloalkyl, —CN, —CO 2 R 7 , —CONR 8 R 9 , —COR 10 , —NO 2 , —SOR 11 , —SO 2 R 12 , —SO 2 OR 13 , —PO 3 R 14 R 15 , —OR 16 , —SR 17 , —NR 18 R 19 , —N(R 20 )COR 21 , —P(R 22 ) 3 , —CO(AA) j , or —CONH(PS) k ;

each of, R 1 , R 2 and R 3 is independently hydrogen, C 1 -C 10 alkyl, halo, haloalkyl, —CN, —CO 2 R 7 , —CONR 8 R 9 , —COR 10 , —NO 2 , —SOR 11 , —SO 2 R 12 , —SO 2 OR 13 , —PO 3 R 14 R 15 , —OR 16 , —SR 17 , —NR 18 R 19 , —N(R 20 )COR 21 , —P(R 22 ) 3 , —CO(AA) j , —CONH(PS) k , or X; with the proviso that no more than one of R 1 , R 2 and R 3 is a —CN group and at least one of R 1 , R 2 and R 3 comprises a substituted or unsubstituted amino group;

(AA) j is a polypeptide chain comprising the same or different amino acids linked together by peptide bonds, wherein j is an integer from 1 to 50;

(PS) k is a sulfated or non-sulfated polysaccharide chain comprising the same or different monosaccharide units connected together by glycosidic linkages, wherein k is an integer from 1 to 50;

each of R 4 to R 22 is independently —H, C 1 -C 10 alkyl, —(CH 2 ) a OR 23 , —CH 2 (CHOH) a R 24 , —CH 2 (CHOH) a CO 2 H, —(CHCO 2 H) a CO 2 H, —(CH 2 ) a NR 25 R 26 , —CH[(CH 2 ) b NH 2 ] a CO 2 H, —CH[(CH 2 ) b NH 2 ] a CH 2 OH, —CH 2 (CHNH 2 ) a CH 2 NR 27 R 28 , —(CH 2 CH 2 O) c R 29 , or —(CH 2 ) d CO(CH 2 CH 2 O) c R 30 ;

each of R 23 to R 30 is independently —H or —CH 3 ;

each of a, b, and d is independently an integer from 1 to 10; and

c is an integer from 1 to 100.

2. The optical diagnostic agent of claim 1 wherein X is -Ar-Y, —C(R 4 )═C(R 5 )-Ar-Y, —N═N-Ar-Y, —CO-Ar-Y, —N(R 6 )-Ar-Y, —O-Ar-Y, —S-Ar-Y, —SO-Ar-Y, or —SO 2 -Ar-Y.

3. The optical diagnostic agent of claim 1 wherein X is -Ar-Y.

4. The optical diagnostic agent of claim 1 wherein X is —C(R 4 )═C(R 5 )-Ar-Y.

5. The optical diagnostic agent of claim 1 wherein X is —N═N-Ar-Y.

6. The optical diagnostic agent of claim 1 wherein Ar is phenyl, naphthyl, biphenyl, pyridyl, pyrazinyl, pyrrolyl, furanyl, and thiopheneyl.

7. The optical diagnostic agent of claim 1 wherein Ar is phenyl, pyridyl, pyrazinyl, pyrrolyl, furanyl, or thiopheneyl.

8. The optical diagnostic agent of claim 1 wherein Ar is phenyl, pyrrolyl, or furanyl.

9. The optical diagnostic agent of claim 1 wherein Ar is phenyl.

10. The optical diagnostic agent of claim 1 wherein Ar is pyrrolyl.

11. The optical diagnostic agent of claim 1 wherein Ar is furanyl.

12. The optical diagnostic agent of claim 1 wherein Y is —H, C 1 -C 10 alkyl, halo, haloalkyl, —CN, —CO 2 R 7 , —CONR 8 R 9 , —COR 10 , —NO 2 , —SO 2 R 12 , —OR 16 , —SR 17 , —NR 18 R 19 , —N(R 20 )COR 21 , —CO(AA) j , or —CONH(PS) k .

13. The optical diagnostic agent of claim 1 wherein Y is —H, alkyl, halo, haloalkyl, —CN, —CO 2 R 7 , —CONR 8 R 9 , —OR 16 , —NR 18 R 19 , or —N(R 20 )COR 21 .

14. The optical diagnostic agent of claim 1 wherein Y is —H, —CN, —CO 2 R 7 , —CONR 8 R 9 , —OR 16 , —NR 18 R 19 , or —N(R 20 )COR 21 .

15. The optical diagnostic agent of claim 1 wherein Y is —H, —CO 2 R 7 , —OR 16 , or NR 18 R 19 .

16. The optical diagnostic agent of claim 1 wherein Y is —H.

17. The optical diagnostic agent of claim 1 wherein each of R 1 to R 3 is independently C 1 -C 10 alkyl, —CN, —CO 2 R 7 , —CONR 8 R 9 , —OR 16 , —NR 18 R 19 , —CO(AA) j , —CONH(PS) k , or X.

18. The optical diagnostic agent of claim 1 wherein each of R 1 to R 3 is independently —CN, —CO 2 R 7 , —CONR 8 R 9 , —NR 18 R 19 , or X.

19. The optical diagnostic agent of claim 1 wherein each of R 1 to R 3 is independently —CN, —CONR 8 R 9 , —NR 18 R 19 , or X.

20. The optical diagnostic agent of claim 1 wherein:

one of R 1 , R 2 , and R 3 is X; and

each of the other two of R 1 , R 2 , and R 3 is independently —CN, —CONR 8 R 9 , or —NR 18 R 19 .

21. The optical diagnostic agent of claim 1 wherein:

one of R 1 , R 2 , and R 3 is —CN, —CONR 8 R 9 , or —NR 18 R 19 ; and

each of the other two of R 1 , R 2 , and R 3 is X.

22. The optical diagnostic agent of claim 1 wherein:

each of R 1 and R 3 is independently —OR 16 , —SR 17 , or —NR 18 R 19 ; and

R 2 is —CN, —CO 2 R 7 , —CONR 8 R 9 , —COR m , —SO 2 R 12 , —CO(AA) j , —CONH(PS) k , or X.

23. The optical diagnostic agent of claim 1 wherein each of R 4 to R 21 is independently —H, C 1 -C 10 alkyl, —(CH 2 ) a OR 23 , —CH 2 (CHOH) a R 24 , —CH 2 (CHOH) a CO 2 H, —(CHCO 2 H) a CO 2 H, —(CH 2 ) a NR 25 R 26 , —CH[(CH 2 ) b NH 2 ] a CO 2 H, —CH[(CH 2 ) b NH 2 ] a CH 2 OH, —CH 2 (CHNH 2 ) a CH 2 NR 27 R 28 , —(CH 2 CH 2 O) c R 29 , or —(CH 2 ) d CO(CH 2 CH 2 O) c R 30 .

24. The optical diagnostic agent of claim 1 wherein each of R 7 to R 21 is independently —H, C 1 -C 10 alkyl, or —(CH 2 ) a OR 23 .

25. The optical diagnostic agent of claim 1 wherein each of R 7 to R 21 is independently —H or C 1 -C 10 alkyl.

26. The optical diagnostic agent of claim 1 wherein (AA) j is a polypeptide chain consisting of amino acids selected from aspartic acid, asparagine, arginine, histidine, lysine, glutamic acid, glutamine, serine, and homoserine.

27. The optical diagnostic agent of claim 26 wherein j is an integer from 1 to 20.

28. The optical diagnostic agent of claim 1 wherein (PS) k is a sulfated or non-sulfated polysaccharide chain consisting of glucose, fructose, mannose, and ribose.

29. The optical diagnostic agent of claim 28 wherein k is an integer from 1 to 20.

30. The optical diagnostic agent of claim 1 wherein each of a, b, and d is independently an integer from 1 to 6.

31. The optical diagnostic agent of claim 1 wherein c is an integer from 1 to 20.

32. The optical diagnostic agent of claim 1 , wherein the optical diagnostic agent is any of formula:

33. The optical diagnostic agent of claim 1 , wherein the optical diagnostic agent is any of formula:

34. The optical diagnostic agent of claim 1 , wherein the optical diagnostic agent is any of formula:

35. The optical diagnostic agent of claim 1 , wherein the optical diagnostic agent is any of formula:

36. The optical diagnostic agent of claim 1 , wherein the optical diagnostic agent is any of formula:

37. The optical diagnostic agent of claim 1 , wherein the optical diagnostic agent is any of formula:

38. The optical diagnostic agent of claim 1 , wherein the optical diagnostic agent is any of formula:

39. The optical diagnostic agent of claim 1 , wherein the optical diagnostic agent is any of formula:

40. A method of imaging a patient comprising:

administering the optical diagnostic agent of claim 1 ,

exposing the administered compound to visible and/or near infrared light,

detecting spectral energy emanating from the administered agent, and

generating an image.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2017
From: NEUMANN, WILLLIAM L.; RAJAGOPALAN, RAGHAVAN; DORSHOW, RICHARD B.
To: MALLINCKRODT INC.
Reel/Frame 043057/0283 →
CHANGE OF NAME Recorded Jul 20, 2017
From: MEDIBEACON DEVELOPMENT, LLC
To: MEDIBEACON , LLC
Reel/Frame 043057/0633 →
CHANGE OF NAME Recorded Jul 20, 2017
From: MALLINCKRODT INC.
To: MALLINCKRODT LLC
Reel/Frame 043279/0620 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2017
From: MALLINCKRODT LLC
To: MEDIBEACON DEVELOPMENT, LLC
Reel/Frame 043279/0714 →
CERTIFICATE OF CONVERSION Recorded Jul 20, 2017
From: MEDIBEACON , LLC
To: MEDIBEACON INC.
Reel/Frame 043280/0001 →
Continuity (3)
Continuation 12305700
Provisional Application 60805568 · Jun 22, 2006
Related Publication 20160090376A1 · Mar 31, 2016